Simplivia Healthcare develops and manufactures high-quality drug-delivery solutions to ensure the safety of healthcare professionals. Simplivias Tevadaptor and Chemfort products use the companys patented Toxi-Guard system, located in the vial adaptor, to allow pressure equalization during use, preventing the escape of hazardous drug vapors into the environment during drug reconstitution and administration as well as preventing airborne contaminants and particles from entering the drug vial. Tevadaptor was formerly a business unit in Teva Pharmaceutical Industries. In May 2019, Simplivia Healthcare incorporated Tevadaptor after the business unit was acquired by FIMI Opportunity Funds, an Israeli private equity firm. In the U.S., Simplivias products are distributed exclusively by B. Braun under the brand name OnGuard. Tevadaptor and Chemfort are approved by the worlds leading regulatory bodies. The companys manufacturing facility in Kiryat Shmona, Israel, meets the most rigorous standards, with both FDA and CE approval.